docetaxel anhydrous has been researched along with Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laga, AC; Lee, MS; Nambudiri, VE; Sauer, M; Shi, CR; Talia, J | 1 |
| Endo, Y; Koike, Y; Kuwatsuka, Y; Miyachi, Y; Okada, K; Utani, A | 1 |
2 other study(ies) available for docetaxel anhydrous and Sclerosis
| Article | Year |
|---|---|
Bilateral lower extremity induration in a patient with leiomyosarcoma.
Topics: Administration, Cutaneous; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Dermatologic Agents; Docetaxel; Edema; Female; Humans; Hyperpigmentation; Intestinal Neoplasms; Lower Extremity; Middle Aged; Ointments; Sclerosis; Skin Pigmentation; Treatment Outcome | 2021 |
Glycosaminoglycan and versican deposits in taxane-induced sclerosis.
Topics: Docetaxel; Glycosaminoglycans; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Middle Aged; Scalp; Scleroderma, Localized; Sclerosis; Skin Neoplasms; Taxoids; Versicans | 2015 |